Goal Commitment and Proactive Health Behavior in Chronic Disease Patients
ClinicalTrials.gov Studies
Summary
A behavioral intervention study registered on ClinicalTrials.gov (NCT07552571) will investigate how goal commitment theory, prospect theory, and evolutionary game theory explain the gap between knowledge and action in chronic disease patients. The parallel controlled trial will enroll patients with hypertension, diabetes mellitus, and dyslipidemia and compare a Stimulus-Organism-Response (SOR) model-based goal commitment intervention against usual care. No regulatory obligations or compliance requirements are imposed by this registry entry.
“Chronic diseases such as hypertension, diabetes, and dyslipidemia are major contributors to mortality and healthcare burden worldwide.”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
This ClinicalTrials.gov registry entry documents a planned parallel controlled intervention study examining goal commitment theory and proactive health behavior in patients with chronic diseases. The study will integrate prospect theory and evolutionary game theory to explore behavioral strategy evolution, and will evaluate a Stimulus-Organism-Response (SOR) model intervention against usual care. The study covers three conditions: hypertension, diabetes mellitus, and dyslipidemia.
Healthcare providers and clinical researchers should note this study's focus on behavioral interventions for chronic disease management. The registry entry itself imposes no compliance obligations but may be of interest to patient advocacy groups and healthcare organizations studying adherence and activation strategies.
Archived snapshot
Apr 28, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Goal Commitment and Proactive Health Behavior in Chronic Disease Patients
N/A NCT07552571 Kind: NA Apr 27, 2026
Abstract
Chronic diseases such as hypertension, diabetes, and dyslipidemia are major contributors to mortality and healthcare burden worldwide. Despite high awareness of health risks, many patients fail to adopt proactive health behaviors due to behavioral inertia and a gap between knowledge and action.
This study aims to investigate the evolution and driving mechanisms of proactive health behavior in patients with chronic diseases based on goal commitment theory. By integrating prospect theory and evolutionary game theory, this study will explore how behavioral strategies evolve under different levels of goal commitment.
In addition, a behavioral intervention based on the Stimulus-Organism-Response (SOR) model will be developed to enhance patient activation and promote adherence to proactive health behaviors. A parallel controlled intervention study will be conducted to evaluate the effectiveness of the goal commitment-based intervention.
The findings of this study are expected to provide theoretical and practical evidence to improve chronic disease management and promote proactive health behaviors.
Conditions: Hypertension, Diabetes Mellitus, Dyslipidemia
Interventions: Goal Commitment-Based Behavioral Intervention, Usual Care
Mentioned entities
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.